![](https://investorshub.advfn.com/uicon/825788.png?cb=1696261088)
Sunday, November 12, 2023 1:51:16 PM
Just cause ppl coined the term ENZO that doesn't equate that Enzolytics has the millions needed to start primate trials. The PRs and Filings have been quite cleat the plans are in place and funding was being secured. With the spac deal we are seeing those plans being executed so that animal studies can begin. It's also laid out on the Biogenysis website quite clearly Clone 3 is still the flagship. You do understand that cocktail of mAbs is ideal to neutralize 100% of all variants as Clone 3 is close to 100% but it isn't. Also gives the Company additional mAbs they can license out.
Again i would review the recently launched Biogenysis website, lots of great information there.
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM